Testimonials

Since Tri-Solfen^® was commercially launched, over 150 million lambs have been treated and over 80% of Australian wool growers are now using Tri-Solfen for their sheep. Here’s what some of them have to say…

‘We have used pain relief for two years now and seen real production gains. We are concerned for the welfare of our animals and will continue to use pain relief to ensure they get the best care.’

Clinton Wise– Wililoo Merino Stud, Woodanilling, W.A.

'It easy to see the difference pain relief makes. Before, lambs would walk away hunched up, even taking a couple of hours to walk back to the paddock. Now they run straight back to Mum and start suckling,” says Rod. “My wool is now sold under the Better Choices brand. I see this as a definite advantage. I think it will be an advantage in the long run, to both me and the industry as a whole.'

Rod Miller– Glenpaen Merino Stud, Horsham, Vic

'After being treated with pain relief my lambs were more content and less stressed. As farmers we are sincere in looking after the welfare of our animals and using pain relief demonstrates this.'

Richard Coole– Frankland, W.A.

'We have been using pain relief for the past three years. We’re impressed by reduced bleeding in the mulesing wound immediately after application. Lambs run straight back to find the ewe, which has dramatically reduced our mortality rates. Flock management, post lamb marking is easier due to the effect of pain relief and the scab healing faster.'

Ryan & Malcom O’Dea– Peepingee Merino Stud, Narrogin, W.A.

'Using pain relief eases the stress and allows lambs to mother up and move back to the paddock easier with faster weight gains.'

Kent Lummis– Waverley Downs, Gilgandra, NSW

Country	Species	Patent
Australia	Sheep	Granted
Australia	Horses, Dogs, Lab animals	Granted
Australia	Cattle	Granted
Australia	Humans	Granted
New Zealand	Sheep, Cattle	Granted
New Zealand	Horses, Dogs, Lab animals	Granted
EU	Humans	Granted
EU	Pig, Sheep, Cattle	Granted
USA	Dogs, Horses, Lab animals	Granted
USA	Humans	Granted
USA	Pig, Sheep, Cattle	Granted
Canada	Horses, Dogs, Lab animals	Granted
Canada	Cattle, Pig	Granted
Canada	Humans	Granted

Advisory Board

Ian Page

Non-Executive Director

Ian is Chief Executive Officer of Dechra Pharmaceuticals, which has a 33% shareholder in Medical Ethics. He joined National Veterinary Services, Dechra’s former services business in 1989 and joined the Board of Dechra in 1997. In October 2010, Ian was appointed as Non-Executive Chairman of Sanford DeLand Asset Management.

Dr Chris Roberts

Human Wound and Regulatory Advisor

Chris has over 20 years’ line management experience of heading clinical research teams. He was previously global head of Smith & Nephew clinical support and market development, where he managed global clinical Phase II and III programmes in the management of venous and pressure ulcers.

Lieutenant Colonel Professor Steven Jeffery

Medical Specialist Advisor

Steve has over 15 years’ experience in military plastic surgery. In 2011 he was awarded the Military Civilian Partnership Award for ‘Regular of the Year’, as well as receiving the Wounds UK ‘Key Contribution’ award and the Smith and Nephew ‘Customer Pioneer of the Year’ award. He has also been awarded Fellowship of the Royal College of Surgeons of England ad eundum. He is an expert adviser to NICE Medical Technologies Evaluation Programme. Steve co-founded the Woundcare 4 Heroes charity, which is already making a big difference to the wound care of both serving and veteran personnel.

Dr Matthew Bayfield

Medical Specialist Scientific Director

Dr Matthew Bayfield, Head of Cardiothoracic Surgery, Strathfield Private Hospital and VMO Cardiothoracic Surgeon, Royal Prince Alfred Hospital.

Professor Peter Windsor

Veterinarian Research Advisor

Peter is a registered specialist veterinary surgeon in New South Wales and an emeritus Professor at Sydney University. He holds a BVSc (Hons), PhD, DVSc and diploma from the European College of Small Ruminant Health Management.

Dr Julian Braidwood

Global Regulatory Affairs Advisor

Julian has held leadership roles and managed international clinical projects with Grampian. He was previously Regulatory Affairs Manager at Novartis Animal Health. He is the Founder and Managing Director of Triveritas, where he is responsible for a team of 40 animal health specialists across the EU and the US.

Tri–Solfen^®

Tri-Solfen^® is a local anaesthetic and antiseptic gel spray that adheres well to wounds and acts as a barrier to environmental stimuli, promotes haemostasis and improves wound healing. Tri-Solfen^® contains two proven topical local anaesthetics; fast-acting Lignocaine for immediate pain relief and long-acting bupivacaine for prolonged post-operative pain relief. Adrenaline is included for its ability to reduce the shock and stress of blood loss, whilst prolonging the anaesthetic action. Tri-Solfen^® also contains Cetrimide; an antiseptic widely used to cleanse skin and wounds and provides protection from bacterial contamination.

Livestock pain relief demand continues to grow

November 3, 2022

By Mark Phelps
Updated November 1 2022 – 11:43am, first published 11:00am

CLAIMS that only limited numbers of Australian livestock producers are using pain relief as part of routine surgical procedures including castration and dehorning have been refuted by industry heavyweights.

Allan Giffard, one of the founders of popular off-the-shelf product Tri-Solfen, said the demand for pain relief products was constantly increasing. “Right from the get go, Australian livestock producers have embraced better welfare in the form of pain relief for their animals,” Mr Giffard said. “As registrations become available, producers are immediately taking to products like Tri-Solfen and meloxicam. “We know pain relief is being used because the demand continues to grow and by the incredible feedback we continue to receive from producers about the benefits of improved animal welfare.” Mr Giffard said the take up of pain relief has been extremely impressive with an estimate of more than 80 per cent of all mulesed sheep now treated. There had also been notable increases in sales of pain relief products for lamb and hot iron tail docking, he said. “The beef sector is a classic story of very rapid adoption of pain relief for dehorning and surgical castration once the technology was registered and became available,” Mr Giffard said. The use of pain relief products has been universally implemented by Australia’s largest beef producers.

Consolidated Pastoral Company chief executive officer Troy Setter even featured in full page advertisements in the rural media promoting the use pain relief for livestock. “The trial work we have done across our properties involving thousands of cattle shows time and time again that providing pain relief to our animals results in less stressed, more productive and profitable animals,” Mr Setter said. “It’s not surprising that the use of pain relief is becoming increasingly widespread across the livestock industries.”

Northern Territory Cattlemen’s Association president David Connolly said he recommended the use of pain relief because it was cost effective and the right thing to do. “You can absolutely see a positive benefit between using it and not using it,” Mr Connolly said. “To anyone out there who is not using Tri-Solfen, grab it, have a go at it, because you will certainly see the benefit.”

Meat and Livestock Australia chief executive officer Jason Strong said Australian beef and lamb producers were increasingly world leaders in best practice animal welfare. “What is really important to communicate is how focused we are on doing the right thing by animals and livestock,” Mr Strong said. “While there are plenty of ways we can look at things that can be done better, what’s most important is the absolute commitment that our industry has on the best animal welfare practices.” Mr Strong said Australia was not only leading the world in the development of solutions, but how those solutions were applied in both the cattle and sheep sector.

“Pain relief and how we actually apply it and its adoption is one of those really good demonstrations as how as an industry we are adjusting to what we see as best practice.” Mr Strong said the approach to invasive procedures such as castration, tail docking and dehorning had changed over time. “Now those types of activities are really top of mind and the use of pain relief is really prevalent in those activities,” he said. “It’s a significant change to what we would have seen decades ago.”

Read full article here

Email alerts